Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain's $10 billion acquisition by private ...

Walgreens Boots Alliance shareholders gave the thumbs-up to the company's private-equity buyout by Sycamore Partners, with ...

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...

Walgreens' $10B sale to Sycamore Partners ends a long decline for one of Chicago’s most iconic companies — and raises ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion ...

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. As management looks to turn the business around, Walgreens has become a special situation stock.

Walgreens previously said it was withdrawing its fiscal-year outlook after reaching a take-private deal with Sycamore Partners.

Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain's $10 billion acquisition by private equity firm Sycamore Partners, the companies announced Friday.

Walgreens Boots Alliance reports Q3 results Walgreens' third quarter sales increased 7.2% year-over-year to $39 billion, up 6.9% on a constant currency basis.